FBRX
Forte Biosciences Inc

2,991
Mkt Cap
$345.62M
Volume
176,145.00
52W High
$35.62
52W Low
$4.90
PE Ratio
-6.21
FBRX Fundamentals
Price
$27.59
Prev Close
$28.81
Open
$28.97
50D MA
$26.42
Beta
0.63
Avg. Volume
226,307.70
EPS (Annual)
-$12.17
P/B
4.11
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Short Interest in Forte Biosciences, Inc. (NASDAQ:FBRX) Expands By 55.5%
Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) was the recipient of a large increase in short interest in January. As of January 15th, there was short interest totaling 795,862 shares, an...
MarketBeat·9d ago
News Placeholder
More News
News Placeholder
Federated Hermes Inc. Acquires 563,147 Shares of Forte Biosciences, Inc. $FBRX
Federated Hermes Inc. boosted its holdings in Forte Biosciences, Inc. (NASDAQ:FBRX - Free Report) by 52.5% in the third quarter, according to the company in its most recent 13F filing with the SEC...
MarketBeat·9d ago
News Placeholder
Traders Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX)
Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) was the target of unusually large options trading activity on Wednesday. Stock traders purchased 30,205 call options on the stock. This is an...
MarketBeat·18d ago
News Placeholder
Stock Traders Buy Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX)
Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 30,205 call options on the stock. This is an increase of...
MarketBeat·2mo ago
News Placeholder
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on developing FB102, which is a proprietary anti-CD122 monoclonal antibody therapeutic...
Business Wire·2mo ago
News Placeholder
Forte Biosciences, Inc. (NASDAQ:FBRX) Given Average Rating of "Moderate Buy" by Brokerages
Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) has earned a consensus rating of "Moderate Buy" from the five research firms that are presently covering the firm, MarketBeat reports. One...
MarketBeat·2mo ago
News Placeholder
Stock Traders Purchase High Volume of Forte Biosciences Call Options (NASDAQ:FBRX)
Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Traders acquired 30,205 call options on the company. This...
MarketBeat·2mo ago
News Placeholder
Forte Biosciences Target of Unusually High Options Trading (NASDAQ:FBRX)
Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) was the recipient of unusually large options trading on Wednesday. Stock investors purchased 30,205 call options on the company. This is an...
MarketBeat·2mo ago
News Placeholder
Forte Biosciences, Inc. (NASDAQ:FBRX) Receives Average Recommendation of "Moderate Buy" from Brokerages
Forte Biosciences, Inc. (NASDAQ:FBRX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the five research firms that are presently covering the company, Marketbeat.com...
MarketBeat·2mo ago
News Placeholder
Forte Biosciences (NASDAQ:FBRX) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPS
Forte Biosciences (NASDAQ:FBRX - Get Free Report) posted its earnings results on Friday. The company reported ($0.99) earnings per share for the quarter, topping the consensus estimate of ($1.04) by...
MarketBeat·3mo ago
<
1
2
...
>

Latest FBRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.